02/02/2017

ESTEVE HAS RENEWED ITS WEBSITE AND ITS PORTAL FOR HEALTH PROFESSIONALS

The website's multi-device design allows users to access information in the format that best fits their needs and preferences.

www.esteve.com includes thorough information about ESTEVE, about its Pharmaceutical, Chemistry and Generics activities, and about its R&D and Sustainability activities.

www.estevefarma.es offers exclusive contents to health professionals and patients.

Barcelona, 1 January 2017.- ESTEVE just renewed its www.esteve.com website with new contents and a modern design adapted to any device to improve accessibility to information and bring the company's day-to-day activities closer to health professionals, patients and the society at large.

The purpose of this renewed portal is to maximize the experience of any user accessing information about ESTEVE and its activities, products and services. Available in three languages (Spanish, Catalan and English), www.esteve.com includes five major sections with specific contents about ESTEVE and thorough information about the Group: mission, vision, values, history, global presence, etc.; its three main activities: Pharmaceutical, Chemistry and Generics; the projects currently underway in the scope of R&D; its Products and Services; and its commitment to and activities in Sustainability, with documents such as the Sustainability Report and the Code of Ethics. Also, the media have a new Press Room to follow ESTEVE's day-to-day activities.

Health professionals as well as patients or caregivers can also access contents specifically created for each one of them. Of high scientific value and provided in a safe environment, these contents include accredited training, scientific up-to-date, support material and advice on several therapeutic categories.

Visit us at www.esteve.com and/or www.estevefarma.es

Follow ESTEVE on Twitter: @ESTEVE_news

Related Information

Last news

  • THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’

    Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...

    read more
  • PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES

    Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...

    read more
  • ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER

    ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.